Clinical Trial Update: A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers [Phase 1]

View source ↗

Summary

Phase 1 safety study update for PF-08046044/SGN-35C in adults with advanced cancers; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma
• Diffuse Large B-cell Lymphoma
• Hodgkin Lymphoma
• Peripheral T-cell Lymphoma

Drugs mentioned

• PF-08046044/SGN-35C

Snippet

Sponsor: Seagen, a wholly owned subsidiary of Pfizer | Conditions: Hodgkin Disease, Lymphoma, T-Cell, Peripheral | Phase 1 | Status: ACTIVE_NOT_RECRUITING